Atlas Trials

Relapsed and Refractory Multiple Myeloma

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed and Refractory Multiple Myeloma

RecordFirmDate
Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma (NCT04155749)Kite, A Gilead Company2019-12-23
IPD in RRMM Characterized With Genomic Abnormalities of Adverse Prognostic (NCT03683277)Intergroupe Francophone du Myelome2019-11-03
A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma (NCT03710915)HitGen Inc.2019-01-12
Study of BCMA CAR-T in Multiple Myeloma (NCT03559764)Allife Medical Science and Technology Co., Ltd.2018-06-01
Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM) (NCT03477643)PETHEMA Foundation2018-04-27
BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma (NCT03661554)The Pregene (ShenZhen) Biotechnology Company, Ltd.2018-04-10
Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma (NCT03029234)Amgen2017-03-31
A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies (NCT02223598)Cleave Biosciences, Inc.2014-08-25
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma (NCT02144038)Novartis Pharmaceuticals2014-07-23
Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma (NCT00932698)Millennium Pharmaceuticals, Inc.2009-10-12
Efficacy Study of CYT997 in Multiple Myeloma (NCT00664378)Gilead Sciences2008-01-01

Track Relapsed and Refractory Multiple Myeloma automatically

Every clearance here is in the API, with alerts when new ones post.